Selskabets formål er produktion og handel og anden dermed i forbindelse stående virksomhed
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 114.5 mio. | 11.8 mio. | 111 mio. | 91.7 mio. | 51 | |
CVR: 34884900
Secondary names: BIOSEARCH TECHNOLOGIES DENMARK A/S, DNA Technology A/S
Previous names: BIOSEARCH TECHNOLOGIES DENMARK A/S, DNA TECHNOLOGY A/S
LGC Biosearch Technologies A/S demonstrates a solid financial health with a consistent revenue stream, achieving 114.5 million DKK in 2025, up from 105.6 million DKK in 2024. Profitability has shown fluctuations, with a notable increase in profit to 11.8 million DKK in 2025, following a dip to 2.6 million DKK in 2024. The company's equity has steadily improved, reaching 91.7 million DKK in 2025, indicating a strong capital position. While profit margins have varied, the overall trajectory suggests stability and potential for growth within the chemical manufacturing sector.
AI-generated summary
Compared to 50 companies in Fremstilling af andre kemiske produkter i.a.n.
Comparison is based on industry median values
Daren Dick joined the board
Lucas-Caspar Schwinner-Strachwitz left the board
Companies in the same industry and area
CVR 45941248
CVR 66119815
CVR 33372116
CVR 41119136
companydata.dk